NYSE : HNGE
Hinge Health, Inc. — Key statistics
Healthcare · Health Information Services · United States
Last price 116.9 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 9.43B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 9.22B |
| Enterprise Value | 8.76B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 2, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 62.47M |
| Shares Outstanding | 80.69M |
| Shares Change (YoY) | +267.86% |
| Shares Change (QoQ) | +1.25% |
| Owned by Insiders (%) | 17.02% |
| Owned by Institutions (%) | 81.94% |
| Float | 50.62M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 85.63 |
| Forward PE | 44.26 |
| PS Ratio | 12.81 |
| Forward PS | 9.46 |
| PB Ratio | 26.63 |
| P/TBV Ratio | 33.16 |
| P/FCF Ratio | 31.80 |
| P/OCF Ratio | 31.72 |
| PEG Ratio | 0.44 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 81.62 |
| EV / Sales | 12.16 |
| EV / EBITDA | 91.51 |
| EV / EBIT | 93.48 |
| EV / FCF | 30.18 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.34 |
| Quick Ratio | 1.07 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.06 |
| Debt / FCF | 0.02 |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 30.38% |
| Return on Assets (ROA) | 7.70% |
| Return on Invested Capital (ROIC) | 15.96% |
| Return on Capital Employed (ROCE) | 27.08% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $501,086 |
| Profits Per Employee | $74,659 |
| Employee Count | 1,437 |
| Asset Turnover | 0.95 |
| Inventory Turnover | 7.24 |
Taxes
| Measure | Value |
|---|
| Income Tax | 1.88M |
| Effective Tax Rate | 1.69% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | n/a |
| 52-Week Price Change | +130.48% |
| 50-Day Moving Average | 98.17 |
| 200-Day Moving Average | 67.06 |
| Relative Strength Index (RSI) | 67.50 |
| Average Volume (20 Days) | 1,912,586 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 6.31M |
| Short Previous Month | 4.83M |
| Short % of Shares Out | 7.82% |
| Short % of Float | 12.47% |
| Short Ratio (days to cover) | 3.51 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 720.06M |
| Gross Profit | 608.75M |
| Operating Income | 93.67M |
| Pretax Income | 110.95M |
| Net Income | 107.29M |
| EBITDA | 95.69M |
| EBIT | 93.67M |
| Earnings Per Share (EPS) | $1.34 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 389.39M |
| Total Debt | 5.89M |
| Net Cash | 468.25M |
| Net Cash Per Share | $5.80 |
| Equity (Book Value) | 344.33M |
| Book Value Per Share | 4.29 |
| Working Capital | 161.91M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 290.79M |
| Capital Expenditures | -666,000 |
| Depreciation & Amortization | 2.02M |
| Net Borrowing | n/a |
| Free Cash Flow | 290.12M |
| FCF Per Share | $3.60 |
Margins
| Measure | Value |
|---|
| Gross Margin | 84.54% |
| Operating Margin | 13.01% |
| Pretax Margin | 15.41% |
| Profit Margin | 15.15% |
| EBITDA Margin | 13.29% |
| EBIT Margin | 13.01% |
| FCF Margin | 40.29% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -267.86% |
| Shareholder Yield | -267.86% |
| Earnings Yield | 1.17% |
| FCF Yield | 3.14% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $114.31 |
| Price Target Difference | -0.01% |
| Analyst Consensus | Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (3Y) | 31.96% |
| EPS Growth Forecast (3Y) | 19.29% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 4.61 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |